Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Firms Could Earn ‘Platinum Card,’ Less Frequent Inspections With Third-Party Audits, Califf Says
Nov 06 2024
•
By
Derrick Gingery
Manufacturers could face fewer FDA inspections if they submit to quality checks in between agency visits.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance